Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy

Objective: To analyze the efficacy and safety of apatinib in the treatment of stage IV osteogenic sarcoma after chemotherapy failure through a single-arm, prospective, and open clinical phase II study. Methods: Information on 34 patients with stage IV osteogenic sarcoma treated with apatinib after f...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Biol Med
Hlavní autoři: Liao, Zhichao, Li, Ting, Zhang, Chao, Liu, Xinyue, Xing, Ruwei, Teng, Sheng, Yang, Yun, Zhao, Gang, Bai, Xu, Zhao, Jun, Yang, Jilong
Médium: Artigo
Jazyk:Inglês
Vydáno: Compuscript 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7309459/
https://ncbi.nlm.nih.gov/pubmed/32587785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2019.0397
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky